Clinical Heterogeneity Of Ambiguous Lineage Leukemias: Search For Optimal Treatment Strategy

EHA Library, Ondřej Hrusak, 184441

From Genetics To Epigenetics In Chronic Myelomonocytic Leukemia

EHA Library, Eric Solary, 184444

Genetic Studies Of Human Erythropoiesis

EHA Library, Vijay Sankaran, 184447

Molecular pathogenesis of Richter syndrome

EHA Library, Gianluca Gaidano, 192912

José Carreras Lecture: AML: The Evil side of gene regulation

EHA Library, Ruud Delwel, 184433

Introduction José Carreras Award & Lecture

EHA Library, Shai Izraeli, 184432

Presentation EHA - José Carreras young investigator award & EHA research grants

EHA Library, Martina Muckenthaler, 184431

Opening address

EHA Library, Anthony Green, 184430

CD34+ AND HUMAN INDUCED PLURIPOTENT STEM CELL (IPSC) DIFFERENTIATION TO TRANSFUSION READY RED BLOOD CELLS

EHA Library, Marie-Jose Claessen, 181419

METABOLIC ADAPTATIONS TO TARGETED THERAPY IN FLT3 MUTATED ACUTE MYELOID LEUKAEMIA (AML)

EHA Library, Paolo Gallipoli, 181423

PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS TREATED WITH NEOD001 ACHIEVE RAPID ORGAN RESPONSES THAT ARE INDEPENDENT OF PREVIOUS PLASMA CELL-DIRECTED THERAPIES

EHA Library, Morie Gertz, 181391

DELETION OF THE F-BOX PROTEIN NIPA (NUCLEAR INTERACTION PARTNER OF ALK) IMPAIRS NPM-ALK DRIVEN TRANSFORMATION

EHA Library, Lena Johanna Lippert, 181414

A NOVEL MODEL OF HUMAN LYMPHO-MYELOID PROGENITOR HIERARCHY BASED ON SINGLE CELL FUNCTIONAL AND TRANSCRIPTIONAL ANALYSIS

EHA Library, Dimitrios Karamitros, 181427

TP53 MUTATIONS, BUT NOT DELETION OF TP53 AND CDKN2A, HAVE INDEPENDENT PROGNOSTIC VALUE IN MANTLE CELL LYMPHOMA TREATED BY THE NORDIC (MCL2 AND MCL3) REGIMEN

EHA Library, Christian Winther Eskelund, 181396

TRANSCRIPTOME SEQUENCING REVEALS DISTINCT SUBTYPES OF MYELODYSPLASIA WITH PROGNOSTIC SIGNIFICANCE

EHA Library, Seishi Ogawa, 181410

TARGETING FLT3 WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS CONFERS POTENT REACTIVITY AGAINST ACUTE MYELOID LEUKEMIA (AML)

EHA Library, HARDIKKUMAR JETANI, 181432

DEFINITION OF PARTIAL RESPONSE IN YOUNGER AML PATIENTS AFTER FIRST INDUCTION COURSE MAY BE EXTENDED BY INCLUSION OF IMMUNOPHENOTYPIC DETECTION OF MEASURABLE RESIDUAL DISEASE IN CR

EHA Library, Sylvia Freeman, 181401

THERAPEUTIC DISRUPTION OF THE BAFF- B-CELL RECEPTOR (BCR) CROSS-TALK IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS

EHA Library, Alexey Danilov, 181405

INTEGRATIVE ANALYSIS OF THE GENOME, EPIGENOME, TRANSCRIPTOME AND THREE-DIMENSIONAL CHROMATIN STRUCTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Renée Beekman, 181404

LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY

EHA Library, W Zeijlemaker, 181400

FIRST EVIDENCE DEMONSTRATING ENGRAFTMENT AND REPOPULATION ADVANTAGE OF GENE-CORRECTED HEMATOPOIETIC REPOPULATING CELLS IN NON-CONDITIONED FANCONI ANEMIA PATIENTS

EHA Library, Julián Sevilla, 181431

IDENTIFICATION OF ABERRANTLY SPLICED GENES AND DEREGULATED PATHWAYS/GENE ONTOLOGY THEMES IN MYELODYSPLASTIC SYNDROME PATIENTS WITH SPLICING FACTOR GENE MUTATIONS

EHA Library, Andrea Pellagatti, 181409

ANALYSIS AND CHARACTERIZATION OF HEMATOLOGIC CANCERS USING A COMPREHENSIVE NGS PANEL COMPRISED OF DNA AND RNA BAITS TARGETING 704 GENES

EHA Library, Timothy Stenzel, 181395

ALPHA-KETOGLUTURATE EXPOSES METABOLIC VULNERABILITIES IN B-CELL LYMPHOMAS

EHA Library, Ricardo Aguiar, 181413

SHORT-TERM FEEDING OF A HIGH-FAT DIET DISTURBS LIPID RAFT/TGF-ΒETA SIGNALING-MEDIATED QUIESCENCE OF HEMATOPOIETIC STEM CELLS IN C57BL/6J MOUSE BONE MARROW

EHA Library, François Hermetet, 181426

PHASE I, OPEN-LABEL TRIAL OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T CELLS IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA

EHA Library, Wanggang Zhang, 181390

LONG-TERM HEALTH STATUS AFTER HSC TRANSPLANTATION FOR THALASSEMIA: THE FRENCH EXPERIENCE

EHA Library, isabelle Thuret, 181418

INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA

EHA Library, Ileana Antony-Debre, 181422

THE VALUE OF NGS PANEL SEQUENCING TO MOLECULARLY DEFINE MYELOID MALIGNANCIES AND CLARIFY BORDERLINE CASES: A STUDY ON 39 GENES IN 1143 PATIENTS

EHA Library, Constance Baer, 181408

GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION.

EHA Library, Jurjen Versluis, 181399

BASELINE AND EARLY POST-TREATMENT CLINICAL AND LABORATORY FACTORS ASSOCIATED WITH SEVERE NEUROTOXICITY FOLLOWING 19-28Z CAR T CELLS IN ADULT PATIENTS WITH RELAPSED B-ALL

EHA Library, Eric Smith, 181430

RITUXIMAB SC AND IV PLUS CHOP SHOW SIMILAR EFFICACY AND SAFETY IN THE RANDOMIZED MABEASE STUDY IN FIRST-LINE DLBCL

EHA Library, Pieternella (Elly) Lugtenburg, 181394

DENOSUMAB INCREASES BONE MINERAL DENSITY IN PATIENTS WITH THALASSEMIA MAJOR AND OSTEOPOROSIS: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE BLIND, PHASE 2B CLINICAL TRIAL

EHA Library, Ersi Voskaridou, 181417

MINIMAL RESIDUAL DISEASE (MRD) BY MULTIPARAMETER FLOW CYTOMETRY (MFC) IN TRANSPLANT ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM): RESULTS FROM THE EMN02/HO95 PHASE 3 TRIAL

EHA Library, Stefania Oliva, 181389

CEBPA-MUTANT ACUTE MYELOID LEUKEMIA IS SENSITIVE TO SMALL-MOLECULE-MEDIATED INHIBITION OF THE MENIN-MLL INTERACTION

EHA Library, Luisa Schmidt, 181421

FUNCTIONAL PROTEOMICS IDENTIFIES SETD2 AS A CRITICAL EFFECTOR OF MLL FUSION PROTEINS TO SAFEGUARD GENOMIC INTEGRITY.

EHA Library, Anna Skucha, 181420

LUSPATERCEPT INCREASES HEMOGLOBIN AND DECREASES TRANSFUSION BURDEN IN ADULTS WITH Β-THALASSEMIA

EHA Library, Antonio Piga, 181416

NEXT GENERATION SEQUENCING (NGS) METHODOLOGY FOR DETERMINING CYTOGENETIC RISK STATUS IN THE DARATUMUMAB PHASE 3 CASTOR AND POLLUX STUDIES IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Christopher Chiu, 181387

MARROW MESENCHYMAL STEM CELLS RESCUE BONE MARROW ENDOTHELIAL CELLS SUFFERING CHEMOTHERAPY STRESS BY TRANSFERRING MITOCHONDRIA THROUGH NANOTUBES

EHA Library, Yonghuai Feng, 181425

GENE THERAPY FOR BETA THALASSEMIA: INITIAL RESULTS FROM THE PHASE I/II TIGET-BTHAL TRIAL OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS GENETICALLY MODIFIED WITH GLOBE LENTIVIRAL VECTOR

EHA Library, Sarah Marktel, 181415

FOXO1 CONTROL CD20 EXPRESSION AND INFLUENCE B-CELL LYMPHOMA RESPONSE TO RITUXIMAB-BASED IMMUNOTHERAPY

EHA Library, Michal Dwojak, 181412

WILMS' TUMOR 1 (WT1) RNA-ELECTROPORATED DENDRITIC CELL VACCINATION AS POST-REMISSION TREATMENT TO PREVENT OR DELAY RELAPSE IN ACUTE MYELOID LEUKEMIA: FINAL RESULTS OF A PHASE II STUDY IN 30 PATIENTS

EHA Library, ZN Berneman, 181428

FIRST-IN-HUMAN MULTICENTER STUDY OF BB2121 ANTI-BCMA CAR T CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS

EHA Library, Yi Lin, 181429

GENETIC ALTERATIONS INVOLVING PROGRAMMED DEATH LIGANDS IN EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOMAS

EHA Library, Keisuke Kataoka, 181411

A NOVEL GENETIC AND MORPHOLOGIC PHENOTYPE OF ARID2-MEDIATED MYELODYSPLASTIC SYNDROMES.

EHA Library, Hideki Makishima, 181407

LOW MYBL2 EXPRESSION OBSERVED IN MYELODYSPLASTIC SYNDROME PATIENTS WITH WORSE PROGNOSIS IS ASSOCIATED WITH ALTERED DNA REPAIR MECHANISMS IN HAEMATOPOETIC STEM CELLS

EHA Library, Paloma Garcia, 181406

Updates in the frontline setting and relapse MM from IMW 2017: An expert roundtable discussion

EHA Library, Delivered by Janssen, 183453

STEP-WISE REPROGRAMMING OF ENDOTHELIAL CELLS INTO IMMUNE-COMPETENT HEMATOPOIETIC STEM CELLS

EHA Library, Jose Gabriel Barcia Duran, 181424

FBXW7 MUTATIONS LEAD TO ACCUMULATION OF NOTCH1, HIF1-ΑLPHA AND C-MYC IN CLL CELLS

EHA Library, Viola Meyer-Pannwitt, 181403

Car-T cells in AML

EHA Library, Attilio Bondanza, 192911

EFFICACY BY CYTOGENETIC RISK STATUS FOR DARATUMUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE OR BORTEZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Jesús San Miguel, 181388

RITUXIMAB MAINTENANCE AFTER AUTOLOGOUS TEM CELL TRANSPLANTATION PROLONGS SURVIVAL IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: FINAL RESULTS OF THE LYMA TRIAL OF THE LYSA/GOELAMS GROUP

EHA Library, Steven Le, 181392

CLINICAL IMPACT OF THE SUBCLONAL ARCHITECTURE AND MUTATIONAL COMPLEXITY IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ferran Nadeu, 181402

RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP

EHA Library, Adriano Venditti, 181398

DEEP MOLECULAR RESPONSE TO GILTERITINIB IMPROVES SURVIVAL IN FLT3 MUTATION-POSITIVE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Altman Jessica, 181397

POLA-R-CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, H Tilly, 181393

All children with sickle cell anemia and an HLA identical sibling should be offered hematopoietic stem cell transplantation

EHA Library, Mariane de Montalembert, 192914

Is transplantation still needed in the era of immunotherapy?

EHA Library, Anna Sureda, 184415

Clonal Evolution in AML

EHA Library, Klaus Metzeler, 192901

Harnessing T-cell mediated anti-leukemic effect: From unmanipulated donor T-cells to tumor-specific and  genetically modified T-cells

EHA Library, Hans-Jochem Kolb, 184419

Immunosenescence: When And How To Vaccinate Older Patients With Malignant Hemopathies?

EHA Library, Raphael Solana, 184422

RBC hydration defects

EHA Library, Carlo Brugnara, 184429

Immune checkpoint inhibitors

EHA Library, Anas Younes, 184414

Engineering NK cells for the treatment of hematologic malignancies

EHA Library, Katy Rezvani, 184425

The long journey of donor search: From sibling to MUD to cord and haplo transplantation

EHA Library, Eliane Gluckman, 184418

Immunosenescence Or Why Are Older Patients More Sensitive To Malignancies?

EHA Library, Tamas Fulop, 184421

Stomatocytosis and allied disorders

EHA Library, Immacolata Andolfo, 184428

Novel aspects of diagnosis of VT

EHA Library, Menno Huisman, 192909

Microenvironment in lymphoma

EHA Library, Georg Lenz, 184413

From dogs to humans... The 60 year long road of allogeneic stem cell transplantation

EHA Library, Rainer Storb, 184417

Elderly task force in hematology: Chair

EHA Library, Dominique BRON, 184420

Functional diversification of human NK cells

EHA Library, Kalle Malmberg, 184424

RBC membrane transport in health and disease

EHA Library, Giel Bosman, 184427

PEG Filgrastim in SCN

EHA Library, Francesca Fioredda, 184410

Anticoagulation in the frail patient / Anticoagulation in the elderly/frail patient (25min)

EHA Library, Kamphuisen Pieter, 192945

The 100.000 genomes project

EHA Library, Willem Ouwehand, 184406

Although ALL is highly curable with conventional chemotherapy, novel therapeutic approaches are still needed to improve outcomes for high-risk or relapsed ALL, especially in adults.Immunotherapeutic approaches have significantly improved the outcome of R

EHA Library, Josep-Maria Ribera, 184402

Emerging treatments for classical myeloproliferative neoplasms

EHA Library, Claire Harrison, 184398

Treatment of extranodal marginal zone B-cell lymphomas

EHA Library, Markus Raderer, 184394

Treatment and sequence in multiple myeloma

EHA Library, Xavier Leleu, 192931

Treatment should be started in every patient with high risk smoldering multiple myeloma

EHA Library, Maria Victoria Mateos, 192932

First-line therapy for CLL in 2017

EHA Library, Alessandra Tedeschi, 192933

Diagnosis and management of Von Willebrand Disease

EHA Library, Giancarlo Castaman, 192934

RBC membrane transport in health and disease

EHA Library, Giel Bosman, 192935

The long journey of donor search: From sibling to MUD to cord and haplo transplantation

EHA Library, Eliane Gluckman, 192936

Should low risk MDS be transplanted?

EHA Library, Nicolaus Kröger, 192937

Stop of TKI in CML

EHA Library, Juan Luis Steegmann, 192938

Highlights in MPN

EHA Library, Claire Harrison, 192939

Highlights in ALL

EHA Library, Ajay Vora, 192940

Neurological complications of sickle cell disease

EHA Library, Fenalla Kirkham, 192941

Diagnosis and management of rare bleeding disorders & gene therapy

EHA Library, Gili Kenet, 192942

PET-CT as biomarker for response in Lymphoma?/ Interim-PET as a valid biomarker for early response in malignant lymphoma; when to perform and how to assess

EHA Library, Josee Zijlstra, 192943

Top 3 AML

EHA Library, Gert Ossenkoppele, 192944

Neutrophil extra cellular traps (NET)

EHA Library, Jean Donadieu, 184409

Drivers of leukemogenesis in congenital neutropenias

EHA Library, Karl Welte, 184408

Syndromes predisposing to hematological malignancies

EHA Library, Christian Kratz, 184405

Immunotherapy of ALL from biology to the clinic and back

EHA Library, Terry Fry, 184401

Update on follicular lymphoma: Time beyond chemotherapy?

EHA Library, Kai Hübel, 184393

Targeting specific mutations in MPN

EHA Library, Ann Mullally, 184397

Molecular profiling of indolent lymphoma

EHA Library, Stefano Pileri, 184392